Den forventede gavn af behandling bør afvejes mod de sikkerhedsfund, der er observeret hos pædiatriske patienter i kliniske undersøgelser (se pkt.
The expected benefit of treatment should be weighed against the safety findings observed for paediatric subjects in the clinical trials Me